Quantitative Investment Management, LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Quantitative Investment Management, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$163,000
+49.5%
26,556
+2.1%
0.01%0.0%
Q4 2018$109,000
-82.3%
26,000
-66.0%
0.01%
-53.8%
Q2 2018$615,000
-28.3%
76,500
-39.5%
0.01%0.0%
Q2 2017$858,000–126,400–0.01%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders